Osaic Holdings
IOVA icon

Osaic Holdings’s Iovance Biotherapeutics IOVA Stock Holding History

Osaic Holdings’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$683K Buy
164,104
+57,005
+53% +$217K ﹤0.01% 3378
2026
Q1 		$376K Buy
107,099
+4,944
+5% +$15.8K ﹤0.01% 3624
2025
Q4 		$279K Sell
102,155
-4,249
-4% -$9.83K ﹤0.01% 3876
2025
Q3 		$237K Buy
106,404
+17,548
+20% +$41.4K ﹤0.01% 4073
2025
Q2 		$154K Buy
88,856
+45,877
+107% +$114K ﹤0.01% 4151
2025
Q1 		$143K Sell
42,979
-43,194
-50% -$223K ﹤0.01% 3909
2024
Q4 		$636K Buy
86,173
+49,529
+135% +$459K ﹤0.01% 2569
2024
Q3 		$344K Buy
36,644
+4,315
+13% +$40.9K ﹤0.01% 3205
2024
Q2 		$259K Sell
32,329
-16,834
-34% -$180K ﹤0.01% 3327
2024
Q1 		$729K Buy
49,163
+10,839
+28% +$126K ﹤0.01% 2624
2023
Q4 		$311K Buy
38,324
+21,924
+134% +$115K ﹤0.01% 3573
2023
Q3 		$74.6K Sell
16,400
-562
-3% -$3.67K ﹤0.01% 4726
2023
Q2 		$119K Buy
16,962
+103
+0.6% +$737 ﹤0.01% 4293
2023
Q1 		$103K Buy
16,859
+3
+0% +$21 ﹤0.01% 4427
2022
Q4 		$107K Sell
16,856
-5,484
-25% -$42.8K ﹤0.01% 4374
2022
Q3 		$214K Buy
22,340
+110
+0.5% +$1.27K ﹤0.01% 3673
2022
Q2 		$245K Sell
22,230
-1,049
-5% -$13.7K ﹤0.01% 3589
2022
Q1 		$388K Sell
23,279
-977
-4% -$15.1K ﹤0.01% 3470
2021
Q4 		$463K Sell
24,256
-1,258
-5% -$27.7K ﹤0.01% 3142
2021
Q3 		$628K Buy
25,514
+202
+0.8% +$4.76K ﹤0.01% 2801
2021
Q2 		$659K Buy
25,312
+717
+3% +$18.6K ﹤0.01% 2729
2021
Q1 		$779K Buy
24,595
+13,115
+114% +$544K ﹤0.01% 2445
2020
Q4 		$533K Sell
11,480
-206
-2% -$8.18K ﹤0.01% 2585
2020
Q3 		$380K Buy
11,686
+249
+2% +$7.63K ﹤0.01% 2685
2020
Q2 		$314K Buy
11,437
+333
+3% +$10.9K ﹤0.01% 2733
2020
Q1 		$332K Buy
+11,104
New +$294K ﹤0.01% 2437

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Osaic Holdings's IOVA Position: Q2 2026 in Review

Osaic Holdings increased its Iovance Biotherapeutics (IOVA) stake by 53% in Q2 2026, buying an estimated $217K and bringing the position to 164,104 shares worth $683K. The position accounts for ﹤0.01% of the portfolio, ranked #3378.

Osaic Holdings first reported a position in IOVA in Q1 2020 and has held it in 26 quarters since. The position peaked at $779K in Q1 2021. 292 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • Osaic Holdings held 164,104 shares of Iovance Biotherapeutics worth $683K as of Q2 2026.
  • Osaic Holdings bought 57,005 Iovance Biotherapeutics shares in Q2 2026, an estimated $217K.
  • Iovance Biotherapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #3378 holding.
  • Osaic Holdings first reported a position in Iovance Biotherapeutics in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Iovance Biotherapeutics position peaked at $779K in Q1 2021.
  • 292 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.